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2-5A[ppp(A2'p),A] and related materials accumulate to greater than micromolar concentrations in vaccinia
virus-infected HeLa cells and in interferon-treated, vaccinia-infected HeLa, CVI, and L929 cells even when
virus replication is not inhibited. A variably complex mixture of authentic 2-5A (n = 2 to 4), nonphosphoryl-
ated cores [(A2'p)nA; n = 2 to 5], and additional compounds of unknown structure was observed.
Modulation of the 2-5A system is one of the many effects
of interferon (IFN) treatment of animal cells (reviewed in
reference 13). The 2-SA synthetase, when activated by
double-stranded RNA, polymerizes ATP into a series of
2',5'-linked oligomers [ppp(A2'p),A, n 2 2]. These oligo-
mers, collectively called 2-5A, bind and activate a latent
cellular endoribonuclease (the 2-5A-dependent RNase,
RNase L or F) capable of cleaving mRNA and rRNA. As
well as synthesizing 2-SA, the synthetase can add AMP in
2'-5' linkage to such metabolites as NAD+, ADP-ribose, and
A5'p45'A (1, 5, 7, 14). Although these products have not
been found in intact cells (5), other unusual 2',5' oligo-
adenylates have been detected, the structure and function of
which have not yet been determined (4, 10).
Vaccinia virus replication is extremely sensitive to IFN in
some strains of L cells grown in suspension in which protein
synthesis, both cellular and viral, is rapidly inhibited. Acti-
vation of the 2-5A-dependent RNase with cleavage of rRNA
and viral RNA has been reported to correlate with this
general inhibition of protein synthesis (2, 6, 8). In contrast,
in other cell lines, vaccinia replication is relatively resistant
to IFN and there is no correlation between 2-5A levels and
inhibition of virus growth (15, 17). In L929, HeLa, and CV1
cells we observed extraordinarily high (greater than
micromolar) levels of 2-5A after vaccinia infection even
when the cells were treated with too little IFN to inhibit
virus growth. Similar high levels of 2-5A accumulated in
untreated HeLa cells (which have high constitutive levels of
2-5A synthetase) in which vaccinia replicates well (17). A
partial explanation for this apparent anomaly was provided
by the observation that in this system activation of the
2-SA-dependent RNase in the intact cell lags considerably
behind the accumulation of 2-5A. The enzyme itself, how-
ever, remained active in cell extracts prepared throughout
infection, suggesting the presence of an inhibitor(s) in the
intact cell (17). Initial results in our laboratory indicated that,
in addition to authentic 2-5A, a variety of related compounds
were present in substantial amounts. It seemed possible
that a further analysis of this 2-5A-related material might
reveal the presence of compounds capable of inhibiting
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activation of the RNase (i.e., analog inhibitors) or, alterna-
tively, reveal products indicative of an alternative func-
tion(s) for the 2-5A system. The results of such an analysis
are presented here.
HeLa cells (S3), L929 cells, and CV1 cells were grown in
monolayer culture with Dulbecco modified Eagle medium
supplemented with 10% heat-inactivated newborn calf se-
rum. IFN treatment for 20 h before infection was done with
400 or 800 reference units of human (Namalva) cell IFN
(Wellcome Research Laboratories; >108 reference units per
mg of protein) for the HeLa and CV1 cells, respectively, and
with mouse L-cell IFN (>5 x 107 reference units per mg of
protein) for the L929 cells. Infection with crude vaccinia
virus (strain WR) was at 10 PFU per cell (17). Trichloroace-
tic acid (TCA)-soluble extracts were prepared from culture
dishes of cells at the indicated time points. In some cases the
extracts were desalted and concentrated on a C18 Sep-Pak
column (Waters Associates) (4). Bacterial alkaline phospha-
tase (BAP; Sigma type III-R) digestions to remove terminal
phosphate groups were performed at 37°C overnight at 0.25
mg/ml (final enzyme concentration) and were monitored by
the addition of tracer amounts of ppp(A2'p)3A[32P]pCp (1 x
103 to 6 x 103 Ci/mmol; Amersham Corp.). High-pressure
liquid chromatography (HPLC) was done on ,uBondapak
C18 columns (Waters Associates) using a gradient of meth-
anol (0 to 12.5% from 0 to 25 min, 12.5 to 25% from 25 to 35
min, and 25% thereafter) in 80 mM ammonium phosphate
buffer, pH 7.0. In this HPLC system (3) the 5' diphosphates
[pp(A2'p),A] elute slightly more slowly and are not com-
pletely resolved from their respective 5' triphosphates
[ppp(A2'p),A]. The 5' monophosphates [p(A2'p),A] are well
resolved. "Cores" [(A2'p),A] elute late and are poorly
resolved (e.g., see Fig. 3A, peak J). For optimum resolution
of cores a potassium phosphate-methanol gradient was used
(3). The radiobinding (RB), radioimmune (RI), and rRNA
cleavage assays were as described previously (11, 12, 17). Of
the assays used the rRNA cleavage and RB assays are
the more specific for authentic 2-SA. Each requires the
minimum structure pp(A2'p)2A for optimum sensitivity (<1
nM). For the RI assay, which uses a polyclonal antiserum,
the corresponding minimum structure is p(A2'p)2A (11). All
of the assays, however, detect additional 2',5' oligoadenyl-
ates with reduced sensitivity, e.g., the RI assay detects
structures containing pA2'pA at 20 to 60 nM (11), and the
rRNA cleavage assay detects the tetramer 5'-monophos-
phate p(A2'p)3A at 100 nM (9). For simplicity, only the
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FIG. 1. HPLC analysis of 2',5' oligoadenylates
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and assayed by the RB assay. The amounts loaded (n
RB assay) were 500 (A) and 280 (B) pmoles undiges
and 250 (B) pmoles with prior BAP digestion (but Ir
digestion). Concentrations are given in terms of tha
of 2-5A (expressed in AMP equivalents) which woulc
same displacement as the unknown in the RB assay
to which dimer, trimer, tetramer, and core standard
in parallel analyses are indicated.
results with the RB and rRNA cleavage assays
here.
TCA-soluble extracts from HeLa cells o
postinfection (p.i.) were fractionated by HP
without prior BAP digestion and assayed by
(Fig. 1A). Typical results for an rRNA cleavag
non-BAP-digested material are presented in F
peaks of RB-positive material were detected
these, B and D are presumably trimer and t
[(p)pp(A2'p),A, n = 2 and 3]. They eluted idei
corresponding standards and activated the 2-.
HeLa (Cont) RNase with activities consistent with the results of the RB
assays. Peaks A, C, and E to L (Fig. 1A) cannot be ascribed14hr p.i. unambiguous structures; only C, E, F, G, and H activated
the RNase (Fig. 2). E or F could be pentamer [(p)pp
(A2'p)4A]. No RB-positive material was obtained after BAP
digestion (Fig. 1A). Thus all 12 peaks in the undigested
material (Fig. 1A) probably contained 5' phosphates. Similar
results with this material were obtained with the RI assay
(data not shown). It is noteworthy (in contrast to the results
with CV1 cells, see below) that negligible (<10 nM)
nonphosphorylated core material was detected in the RI
assay in the undigested material (Fig. 1A).
2 'p)n A Very different results were obtained upon infection of the
core) same cells after IFN treatment (Fig. 1B). Once again peaks
4 (K and M, Fig. 1B) presumably corresponding to trimer and
tetramer 2-5A were identified as described above. The
remaining peaks (L and N to T) cannot be ascribed struc-
tures; of these, only 0 was positive in the rRNA cleavage
assay (controls in which 2-5A was added to the assays failed
80 to detect inhibitory material). The significance of the residual
HeLa (IF) RB activity in the BAP digest, despite complete digestion of
the internal standard ppp(A2'p)3A[32P]pCp to (A2'p)3-
14hr p.i. A[32PIpC, is unclear.
Complex patterns of 2',5' oligoadenylates were also ob-
tained from IFN-treated, vaccinia virus-infected CV1 cells.
A particularly complex example is shown in Fig. 3 without or
with prior BAP digestion (Fig. 3A and B, respectively). In
addition to peaks of material positive in RB and rRNA
cleavage assays which eluted at positions corresponding to
trimer, tetramer, and pentamer 2-SA (Fig. 3A, peaks A, B,
(A2'p)nA and C), a variety of additional peaks was detected. These
(core) appeared to differ substantially from those present in the
corresponding HeLa extract (Fig. 1B). The major differences
are that with the CV1 material (peaks D to I) the values
measured in the RI assay were high compared to the values
measured in the RB assay, and these peaks were active in
the rRNA cleavage assays at levels consistent with their RB
values (contrast peaks P to T in Fig. 1B). In addition, the
B0 CV1 material yielded many RB-positive peaks after BAP
digestion (Fig. 3B) and contained a major peak J without
BAP digestion (Fig. 3A) at a position corresponding to the
extracted from core standard. This peak contained enough material (9 ,uM in
vaccinia virus, the RI assay) to rerun in an alternative HPLC system (see
ted (B) vaccinia above and reference 3) monitoring A260. This confirmed that
,C with (A) or the material consisted of nonphosphorylated trimer,
rneasured by the tetramer, pentamer, and hexamer core 2-SA [(A2'p),A, n =
nted and 220 (A) 2 to 5, data not shown].
weasured before There was, in fact, considerable variation in 2-5A synthe-
it concentration tase levels and quantitative and qualitative differences in
have given the the complexity of the pattern of 2',5' oligoadenylates ob-
t- The positions tained with CV1 cell lines of different origins. For example,
2-5A migrated the level of total RB-positive material at 23 h p.i. in IFN-
treated cells varied from 60 nM to 30 ,uM (in 2-5A equiva-
lents). Culture conditions also appeared to greatly affect the
results. In general, sparse cultures gave substantially lower
are presented levels of 2',5' oligoadenylates in cells than did confluent
cultures. As might be expected the pattern also varied with
ibtained 14 h time p.i.
'LC with and Simpler patterns were obtained in a less extensive analysis
the RB assay of 2',5' oligoadenylates in IFN-treated L929 cells 12 h p.i.
e assay on the with vaccinia. Four peaks of RB-positive material were
rig. 2. Twelve obtained, all of which were BAP sensitive. Only two were
(Fig. 1A). Of active in the rRNA cleavage assay, and these eluted in
tetramer 2-5A positions consistent with their being trimer and tetramer
ntically to the 2-5A. In general, much less RB-positive material was ob-
5A-dependent tained from these cells.
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FIG. 2. Activation of 2-5A-dependent RNase by HPLC-fractionated 2',5' oligoadenylates extracted from control HeLa cells at 14 h p.i.
with vaccinia virus. Peak samples from the undigested material analyzed in Fig. 1A were incubated with an IFN-treated L-cell cytoplasmic
extract (S-10). RNA isolated from such incubations was electrophoresed in a 1.6% neutral agarose gel (17); a photograph of the ethidium
bromide-stained gel is shown. Specific 2-5A-dependent RNase cleavage products of 28S and 18S rRNAs are marked by arrows to the right
of the gel. The top left portion of the gel contained incubations with 0, 0.25, 0.75, 2.5, 7.5, and 25 nM concentrations (final concentration in
AMP equivalents) of a ppp(A2'p)3A standard. The fraction numbers above the gel correspond to those shown in Fig. 1A. Tracks labeled 1/10
or 1/100 indicate that corresponding dilutions of the HPLC fractions were assayed. All incubations (8 pd) included 2 ,ul of sample and 6 p.l of
S-10.
This analysis has shown that 2',5' oligoadenylates in
vaccinia-infected cells can consist of a variably complex
mixture of authentic 2-5A, nonphosphorylated core 2-5A,
and numerous additional compounds of unknown structure.
These findings contrast with those in other IFN-virus sys-
tems. In IFN-treated, encephalomyocarditis virus-infected
L cells, only authentic 2-5A (trimer and tetramer) and cores
were detected (12). Little authentic 2-5A was detected in
CV1 cells infected with simian virus 40 and then treated with
IFN, but core 2-5A and several oligoadenylates of unknown
structure were found (10). In IFN-treated, herpes simplex
virus type 1-infected Chang cells, authentic 2-5A (trimer and
tetramer) was detected as well as two related compounds
which were capable of acting as inhibitors of the 2-5A-
dependent RNase in cell extracts (4). These related com-
pounds were present in concentrations too low to permit
further characterization (4). It is not clear whether any of the
unknowns in the systems described above correspond to any
of those detected in the present study.
The reason(s) for the lag in vaccinia-infected cells between
accumulation of high levels of 2-5A and activation of the
RNase (17) remains unclear. In our study, assay of selected
peak fractions (not themselves capable of activating the
RNase) failed to detect significant analog inhibitory activity
analogous to that found in IFN-treated, herpesvirus-infected
cells (4). It remains possible that such inhibitors are pro-
duced at an early or crucial time during infection or are
localized at high concentrations near the RNase. Alterna-
tively, another type of inhibitor of the RNase that is not
related to 2-5A could be present which is lost during the
preparation of cell extracts.
Clearly, much of the variability in the amount and nature
of the 2',5' oligoadenylates in vaccinia-infected cells
reflects differences between cell lines. Even within a given
cell line, however, the results were so variable as to suggest
extreme sensitivity to time and multiplicity of infection,
variation in the IFN response and the exact growth state of
the cells. With cells yielding sufficient 2',5' oligoadenylates
for further characterization to appear possible a priori, the
quantitative and qualitative variation from experiment to
experiment meant that none of the unknowns could be
reproducibly obtained in sufficient yield for structural
determination. Accordingly, no further analysis was at-
tempted. The nature and role of the additional material,
therefore, remains unclear. It cannot be excluded that
these compounds are produced by the fortuitous modifica-
tion of 2-5A by vaccinia-encoded enzymes (e.g., capping
enzyme; see reference 16) and are not of widespread
biological relevance. On the other hand, authentic 2-5A is
produced in relatively large amounts in a variety of IFN-
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